Shaping the Future of HIV Research

Melanie Ott, MD, PhD, is Director of the Gladstone Institute of Virology and Senior Vice President of the Gladstone Institutes, and a professor of medicine at University of California, San Francisco. 

Dr. Ott’s work has focused on HIV and hepatitis C and expanded into other viruses such as Zika, influenza, and SARS-CoV-2. She has focused much of her work on HIV transcription and identifying new molecular targets for treatments and cure, new diagnostics, and the potential for pan-viral therapeutics. A regular reviewer of grant applications for amfAR, Dr. Ott is a recipient of NIH MERIT and DP1 Avantgarde Awards, an elected member of the Association of American Physicians, and a Fellow of the American Academy of Microbiology. 

amfAR VP and Director of Research Dr. Andrea Gramatica spoke with Dr. Ott about her work, the promise of new and emerging technologies, and what she expects to see in the year ahead.

---